1 We investigated how manipulations of the degree of activation of adenosine A 1 and A 2A receptors in¯uences the action of the neuropeptide, calcitonin gene-related peptide (CGRP) on synaptic transmission in hippocampal slices. Field excitatory post-synaptic potentials (EPSPs) from the CA1 area were recorded. 2 When applied alone, CGRP (1 ± 30 nM) was without eect on ®eld EPSPs. However, CGRP (10 ± 30 nM) signi®cantly increased the ®eld EPSP slope when applied to hippocampal slices in the presence of the A 1 receptor antagonist, 1,3-dipropyl-8-cyclopenthyl xanthine (DPCPX, 10 nM), or in the presence of the A 2A adenosine receptor agonist CGS 21680 (10 nM). 3 The A 2A receptor antagonist, ZM 241385 (10 nM) as well as adenosine deaminase (ADA, 2 U ml 71 ), prevented the enhancement of ®eld EPSP slope caused by CGRP (30 nM) in the presence of DPCPX (10 nM), suggesting that this eect of CGRP requires the concomitant activation of A 2A adenosine receptors by endogenous adenosine. 4 The protein kinase-A inhibitors, N-(2-guanidinoethyl)-5-isoquinolinesulfonamide (HA-1004, 10 mM) and adenosine 3',5'-cyclic monophosphorothioate, Rp-isomer (Rp-cAMPS, 50 mM), as well as the inhibitor of ATP-sensitive potassium (K ATP ) channels, glibenclamide (30 mM), prevented the facilitation of synaptic transmission caused by CGRP (30 nM) in the presence of DPCPX (10 nM), suggesting that this eect of CGRP involves both K ATP channels and protein kinase-A. 5 It is concluded that the ability of CGRP to facilitate synaptic transmission in the CA1 area of the hippocampus is under tight control by adenosine, with tonic A 1 receptor activation by endogenous adenosine`braking' the action of CGRP, and the A 2A receptors triggering this action.